Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ankylosing Spondylitis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ankylosing Spondylitis Drugmarket, defines the market attractiveness level of Ankylosing Spondylitis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ankylosing Spondylitis Drug industry, describes the types of Ankylosing Spondylitis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ankylosing Spondylitis Drug market and the development prospects and opportunities of Ankylosing Spondylitis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ankylosing Spondylitis Drug market in Chapter 13.
By Player:
Centocor
Pfizer
Eisai
Mitsubishi Tanabe
Abbott
Wyeth
Amgen
Takeda
Johnson & Johnson
Schering-Plough
By Type:
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
By End-User:
Adults
Juveniles
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ankylosing Spondylitis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ankylosing Spondylitis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ankylosing Spondylitis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ankylosing Spondylitis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ankylosing Spondylitis Drug Market Analysis and Outlook to 2022
-
7.1 Global Ankylosing Spondylitis Drug Consumption (2017-2022)
-
7.2 United States Ankylosing Spondylitis Drug Consumption (2017-2022)
-
7.3 Europe Ankylosing Spondylitis Drug Consumption (2017-2022)
-
7.4 China Ankylosing Spondylitis Drug Consumption (2017-2022)
-
7.5 Japan Ankylosing Spondylitis Drug Consumption (2017-2022)
-
7.6 India Ankylosing Spondylitis Drug Consumption (2017-2022)
-
7.7 South Korea Ankylosing Spondylitis Drug Consumption (2017-2022)
8 Region and Country-wise Ankylosing Spondylitis Drug Market Analysis and Outlook to 2028
-
8.1 Global Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
-
8.2 United States Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
-
8.4 China Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
-
8.6 India Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Ankylosing Spondylitis Drug Consumption Forecast (2022-2028)
9 Global Ankylosing Spondylitis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Ankylosing Spondylitis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cimzia Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Enbrel Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Humira Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Remicade Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Simponi Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Ankylosing Spondylitis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Juveniles Consumption and Growth Rate (2017-2022)
10 Global Ankylosing Spondylitis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cimzia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Simponi Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Juveniles Consumption Forecast and Growth Rate (2022-2028)
11 Global Ankylosing Spondylitis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ankylosing Spondylitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ankylosing Spondylitis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ankylosing Spondylitis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ankylosing Spondylitis Drug Market Competitive Analysis
-
14.1 Centocor
-
14.1.1 Centocor Company Details
-
14.1.2 Centocor Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Centocor Ankylosing Spondylitis Drug Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Ankylosing Spondylitis Drug Product and Service
-
14.3 Eisai
-
14.3.1 Eisai Company Details
-
14.3.2 Eisai Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eisai Ankylosing Spondylitis Drug Product and Service
-
14.4 Mitsubishi Tanabe
-
14.4.1 Mitsubishi Tanabe Company Details
-
14.4.2 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Product and Service
-
14.5 Abbott
-
14.5.1 Abbott Company Details
-
14.5.2 Abbott Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abbott Ankylosing Spondylitis Drug Product and Service
-
14.6 Wyeth
-
14.6.1 Wyeth Company Details
-
14.6.2 Wyeth Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Wyeth Ankylosing Spondylitis Drug Product and Service
-
14.7 Amgen
-
14.7.1 Amgen Company Details
-
14.7.2 Amgen Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Ankylosing Spondylitis Drug Product and Service
-
14.8 Takeda
-
14.8.1 Takeda Company Details
-
14.8.2 Takeda Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Takeda Ankylosing Spondylitis Drug Product and Service
-
14.9 Johnson & Johnson
-
14.9.1 Johnson & Johnson Company Details
-
14.9.2 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Ankylosing Spondylitis Drug Product and Service
-
14.10 Schering-Plough
-
14.10.1 Schering-Plough Company Details
-
14.10.2 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Schering-Plough Ankylosing Spondylitis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ankylosing Spondylitis Drug
-
Figure Ankylosing Spondylitis Drug Picture
-
Table Global Ankylosing Spondylitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ankylosing Spondylitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ankylosing Spondylitis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ankylosing Spondylitis Drug Consumption by Country (2017-2022)
-
Figure United States Ankylosing Spondylitis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Ankylosing Spondylitis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Ankylosing Spondylitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Ankylosing Spondylitis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Ankylosing Spondylitis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ankylosing Spondylitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ankylosing Spondylitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cimzia Consumption and Growth Rate (2017-2022)
-
Figure Global Enbrel Consumption and Growth Rate (2017-2022)
-
Figure Global Humira Consumption and Growth Rate (2017-2022)
-
Figure Global Remicade Consumption and Growth Rate (2017-2022)
-
Figure Global Simponi Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Juveniles Consumption and Growth Rate (2017-2022)
-
Figure Global Cimzia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Simponi Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Juveniles Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ankylosing Spondylitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ankylosing Spondylitis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Centocor (Foundation Year, Company Profile and etc.)
-
Table Centocor Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Centocor Ankylosing Spondylitis Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Ankylosing Spondylitis Drug Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Ankylosing Spondylitis Drug Product and Service
-
Table Mitsubishi Tanabe (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Ankylosing Spondylitis Drug Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Ankylosing Spondylitis Drug Product and Service
-
Table Wyeth (Foundation Year, Company Profile and etc.)
-
Table Wyeth Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wyeth Ankylosing Spondylitis Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Ankylosing Spondylitis Drug Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Ankylosing Spondylitis Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Ankylosing Spondylitis Drug Product and Service
-
Table Schering-Plough (Foundation Year, Company Profile and etc.)
-
Table Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Schering-Plough Ankylosing Spondylitis Drug Product and Service
-
